ORGANIZATION AND ACTIVITIES OF THE QUALITY-OF-LIFE COMMITTEE OF THE NATIONAL-CANCER-INSTITUTE-OF-CANADA (NCI-C) CLINICAL-TRIALS GROUP

被引：0
|
作者：
OSOBA, D [1 ]
机构：
[1] BRITISH COLUMBIA CANC AGCY,VANCOUVER,BC,CANADA
来源：
QUALITY OF LIFE RESEARCH | 1993年 / 2卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [31] PHASE-II STUDY OF ORAL MENOGARIL AS 1ST LINE CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-STUDY
    STEWART, DJ
    EISENHAUER, EA
    SKILLINGS, J
    PRITCHARD, KI
    BUCKMAN, R
    VANDENBERG, T
    VERMA, S
    AITKEN, S
    NORRIS, B
    ANNALS OF ONCOLOGY, 1992, 3 (03) : 201 - 204
  • [32] IMPROVED SURVIVAL IN PATIENTS WITH POOR-PROGNOSIS MALIGNANT-MELANOMA TREATED WITH ADJUVANT LEVAMISOLE - A PHASE-III STUDY BY THE NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP
    QUIRT, IC
    SHELLEY, WE
    PATER, JL
    BODURTHA, AJ
    MCCULLOCH, PB
    MCPHERSON, TA
    PATERSON, AHG
    PRENTICE, R
    SILVER, HKB
    WILLAN, AR
    WILSON, K
    ZEE, B
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (05) : 729 - 735
  • [33] PHASE-II STUDY OF ACIVICIN AS A 72-HR CONTINUOUS INFUSION IN PATIENTS WITH UNTREATED COLORECTAL-CANCER - A NATIONAL-CANCER-INSTITUTE-OF-CANADA CLINICAL-TRIALS GROUP-STUDY
    EISENHAUER, EA
    MAROUN, JA
    FIELDS, AL
    WALDE, PLD
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (04) : 375 - 378
  • [34] Early closure of clinical trials: The experience of the National Cancer Institute of Canada Clinical Trials Group.
    Parulekar, W.
    Pater, J. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 314S - 314S
  • [35] Quality-of-life assessment in the symptom management trials of the National Cancer Institute - Supported Community Clinical Oncology Program
    Buchanan, DR
    O'Mara, AM
    Kelaghan, JW
    Minasian, LM
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) : 591 - 598
  • [36] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [37] RANDOMIZED TRIAL OF INTERFERON MAINTENANCE IN MULTIPLE-MYELOMA - A STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP
    BROWMAN, GP
    BERGSAGEL, D
    SICHERI, D
    OREILLY, S
    WILSON, KS
    RUBIN, S
    BELCH, A
    SHUSTIK, C
    BARR, R
    WALKER, I
    JAMES, K
    ZEE, B
    JOHNSTON, D
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (09) : 2354 - 2360
  • [38] ECONOMIC-EVALUATION AND QUALITY-OF-LIFE ASSESSMENTS IN CANCER CLINICAL-TRIALS - THE CHART TRIAL
    MORRIS, J
    GODDARD, M
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) : 766 - 770
  • [39] QUALITY-OF-LIFE IN STAGE-II BREAST-CANCER - AN INSTRUMENT FOR CLINICAL-TRIALS
    LEVINE, MN
    GUYATT, GH
    ARNOLD, A
    BUSH, H
    ABUZAHRA, HT
    DEPAUW, S
    BREAST CANCER RESEARCH AND TREATMENT, 1986, 8 (01) : 102 - 102
  • [40] Anticoagulation and bleeding: A pooled analysis of lung cancer trials of the National Cancer Institute of Canada Clinical Trials Group
    Le Maitre, A.
    Ding, K.
    Shepherd, F. A.
    Leighl, N. B.
    Arnold, A.
    Seymour, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345